angiotensin ii, des-phe(8)- has been researched along with phenylephrine in 11 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benter, IF; Diz, DI; Ferrario, CM | 1 |
| Campagnole-Santos, MJ; Côrtes, SF; Lemos, VS; Santos, RA; Silva, DM | 1 |
| Langeveld, B; Roks, AJ; Tio, RA; van Gilst, WH; Zijlstra, F | 1 |
| Averill, DB; Diz, DI; Ferrario, CM; Gallagher, PE; Ganten, D; Garcia-Espinosa, MA | 1 |
| Gao, YJ; Lee, RM; Lu, C; Zhao, AX | 1 |
| Alenina, N; Bader, M; Gao, YJ; Lee, RM; Lu, C; Santos, RA | 1 |
| Alsaadon, H; Habiyakare, B; Hayes, A; Mathai, ML; Zulli, A | 1 |
| Açikalin, Ö; Bölükbaşi Hatip, FF; Hatip-Al-Khatib, I; Tan, RF | 1 |
| Banères, JL; Boularan, C; Denis, C; Dubroca, C; Galandrin, S; Galés, C; M'Kadmi, C; Marie, J; N'Guyen, D; Nicaise, Y; Pathak, A; Pilette, C; Seguelas, MH; Sénard, JM | 1 |
| Ferreira, AJ; Fraga-Silva, RA; Lautner, RQ; Santos, RA | 1 |
| Bomfim, GF; Bressan, AFM; Carneiro, FS; Freitas, RA; Giachini, FR; Junior, RRP; Justina, VD; Lima, VV | 1 |
11 other study(ies) available for angiotensin ii, des-phe(8)- and phenylephrine
| Article | Year |
|---|---|
Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Hypertension; Infusions, Intravenous; Injections, Intravenous; Male; Peptide Fragments; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Time Factors; Vasoconstrictor Agents | 1995 |
Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Aorta; Bradykinin Receptor Antagonists; Captopril; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Male; Mice; Peptide Fragments; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Bradykinin; Vasoconstriction | 2002 |
Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.
Topics: Angiotensin I; Animals; Aorta, Abdominal; Aorta, Thoracic; Hypertrophy; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Methacholine Chloride; Peptide Fragments; Phenylephrine; Rats; Rats, Wistar; Sodium Nitrite; Stents; Tunica Intima; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Baroreflex; Biguanides; Blood Pressure; Female; Heart Rate; Male; Mice; Peptide Fragments; Phenylephrine; Rats; Rats, Sprague-Dawley; Renin; Solitary Nucleus | 2008 |
Modulation of vein function by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Animals; Endothelium, Vascular; In Vitro Techniques; Male; Nitric Oxide; Peptide Fragments; Phenylephrine; Potassium Channels; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasoconstriction; Vasodilation; Vena Cava, Inferior | 2011 |
Mas receptors in modulating relaxation induced by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Animals; Aorta, Thoracic; Endothelium, Vascular; Mice; Mice, Knockout; Peptide Fragments; Phenylephrine; Potassium Chloride; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilation | 2011 |
Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7).
Topics: Acetylcholine; Angiotensin I; Angiotensins; Animals; Aorta, Abdominal; Aorta, Thoracic; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Iliac Artery; Male; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Phenylephrine; Rabbits; Receptors, G-Protein-Coupled; Renal Artery; Vasoconstriction; Vasodilation | 2014 |
Effect of Angiotensin-(1-7) on Aortic Response, TNF-α, IL-1β and Receptor for Advanced Glycation Endproduct in Rat's Adjuvant-Induced Arthritis.
Topics: Acetylcholine; Angiotensin I; Animals; Aorta, Thoracic; Arthritis, Experimental; Blood Pressure; Interleukin-1beta; Male; Peptide Fragments; Phenylephrine; Potassium Chloride; Rats, Sprague-Dawley; Rats, Wistar; Receptor for Advanced Glycation End Products; Tumor Necrosis Factor-alpha; Vasoconstriction | 2016 |
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Abdominal; beta-Arrestins; Cardiotonic Agents; Cells, Cultured; HEK293 Cells; Humans; Muscles; Peptide Fragments; Phenylephrine; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sensitivity and Specificity; Signal Transduction; Vasoconstriction | 2016 |
Vascular Reactivity of Isolated Aorta to Study the Angiotensin-(1-7) Actions.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Aorta; In Vitro Techniques; Mice; Peptide Fragments; Phenylephrine; Rats; Vasodilation; Vasodilator Agents | 2017 |
Angiotensin (1-7)-attenuated vasoconstriction is associated with the Interleukin-10 signaling pathway.
Topics: Angiotensin I; Animals; Interleukin-10; Janus Kinase 1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Phenylephrine; STAT3 Transcription Factor; Time Factors; Vasoconstriction | 2020 |